Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct Cleavage Properties of Cathepsin B Compared to Cysteine Cathepsins Enable the Design and Validation of a Specific Substrate for Cathepsin B over a Broad pH Range. | Biochemistry | 2023 | 37459182 | PubTator, text mining | PubMed |
| Comprehensive prognostic and immunological analysis of Ubiquitin Specific Peptidase 28 in pan-cancers and identification of its role in hepatocellular carcinoma cell lines. | Aging (Albany NY) | 2023 | 37450415 | PubTator, text mining | PubMed |
| Weighted gene coexpression network analysis reveals negative regulation of hypertrophic cardiomyopathy by carboxylesterase 1 and cathepsin C. | Gen Physiol Biophys | 2023 | 37449320 | PubTator, text mining | PubMed |
| Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice. | Front Immunol | 2023 | 37441081 | PubTator, text mining | PubMed |
| Development and validation of asthma risk prediction models using co-expression gene modules and machine learning methods. | Sci Rep | 2023 | 37438356 | PubTator, text mining | PubMed |
| Lack of eosinophil extracellular trap formation due to failure of plasma membrane breakdown in the absence of elastase. | Blood Adv | 2023 | 37428870 | PubTator, text mining | PubMed |
| E-64c-Hydrazide Based Cathepsin C Inhibitors: Optimizing the Interactions with the S1'-S2' Area. | ChemMedChem | 2023 | 37424408 | PubTator, text mining | PubMed |
| TECPR1 is activated by damage-induced sphingomyelin exposure to mediate noncanonical autophagy. | EMBO J | 2023 | 37409525 | PubTator, text mining | PubMed |
| Novel Anti-Inflammatory Approaches to COPD. | Int J Chron Obstruct Pulmon Dis | 2023 | 37408603 | PubTator, text mining | PubMed |
| The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies. | Front Immunol | 2023 | 37398678 | PubTator, text mining | PubMed |
| Identification of a novel compound heterozygous mutation and a homozygous mutation of SLURP1 in Chinese families with Mal de Meleda. | BMC Med Genomics | 2023 | 37393290 | PubTator, text mining | PubMed |
| The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma. | BMC Cancer | 2023 | 37386391 | PubTator, text mining | PubMed |
| Temporary serine protease inhibition and the role of SPINK2 in human bone marrow. | iScience | 2023 | 37378330 | PubTator, text mining | PubMed |
| Mechanisms of Neutrophil Extracellular Trap Formation and Regulation in Cancers. | Int J Mol Sci | 2023 | 37373412 | PubTator, text mining | PubMed |
| Weaving the nest: extracellular matrix roles in pre-metastatic niche formation. | Front Oncol | 2023 | 37350937 | PubTator, text mining | PubMed |
| Plasma Proteomic Kinetics in Response to Acute Exercise. | Mol Cell Proteomics | 2023 | 37343698 | PubTator, text mining | PubMed |
| Cathepsins in oral diseases: mechanisms and therapeutic implications. | Front Immunol | 2023 | 37334378 | PubTator, text mining | PubMed |
| A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer. | Medicine (Baltimore) | 2023 | 37327286 | PubTator, text mining | PubMed |
| A cathepsin C-like protease mediates the post-translation modification of Toxoplasma gondii secretory proteins for optimal invasion and egress. | mBio | 2023 | 37326431 | PubTator, text mining | PubMed |
| Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities. | Drugs Aging | 2023 | 37316689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=16